Novel mechanisms of macrolide resistance revealed by in vitro selection and genome analysis in Mycoplasma pneumoniae
Mycoplasma pneumoniae is an important pathogen causing upper and lower respiratory tract infections in children and other age groups. Macrolides are the recommended treatments of choice for M. pneumoniae infections. However, macrolide resistance in M. pneumoniae is increasing worldwide, which compli...
Main Authors: | Na Wang, Xiaogang Xu, Li Xiao, Yang Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-05-01
|
Series: | Frontiers in Cellular and Infection Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcimb.2023.1186017/full |
Similar Items
-
Novel Knowledge of Macrolide Resistance in <i>Mycoplasma pneumoniae</i> by Azithromycin Exposure
by: Tomohiro Oishi, et al.
Published: (2024-01-01) -
Efficacy of glucocorticoids for the treatment of macrolide refractory mycoplasma pneumonia in children: meta-analysis of randomized controlled trials
by: Hwan Soo Kim, et al.
Published: (2019-12-01) -
Efficacy of doxycycline therapy for macrolide-resistant Mycoplasma pneumoniae pneumonia in children at different periods
by: Ying Chen, et al.
Published: (2024-03-01) -
Macrolide-Resistant and Macrolide-Sensitive <i>Mycoplasma pneumoniae</i> Pneumonia in Children Treated Using Early Corticosteroids
by: Hye Young Han, et al.
Published: (2021-03-01) -
Macrolide versus Non-Macrolide in Combination with Steroids for the Treatment of Lobar or Segmental <i>Mycoplasma pneumoniae</i> Pneumonia Unresponsive to Initial Macrolide Monotherapy
by: Eunha Bae, et al.
Published: (2022-09-01)